Search

Author/Creator Ye, Xiaobu

1. 143 The Combination of anti-TIM-3 and anti-PD-1 Checkpoint Inhibitors With Focused Radiation Resulted in a Synergistic Antitumor Immune Response in a Preclinical Glioma Model. Issue Volume 62:Issue CN Supp 1(2015)Supplement 1 (August 2015)

Authors:
Kim, Jennifer E.; Patel, Mira A.; Mangraviti, Antonella; Velarde, Esteban; Theodros, Debebe; Mathios, Dimitris; Jackson, Christopher Mitchell; Tyler, Betty; Ye, Xiaobu; Brem, Henry; Pardoll, Drew; Lim, Michael
Journal:
Neurosurgery
Issue:
Volume 62:Issue CN Supp 1(2015)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma. Issue 10 (24th May 2015)

Authors:
Gerstner, Elizabeth R.; Ye, Xiaobu; Duda, Dan G.; Levine, Michael A.; Mikkelsen, Tom; Kaley, Thomas J.; Olson, Jeffrey J.; Nabors, Burt L.; Ahluwalia, Manmeet S.; Wen, Patrick Y.; Jain, Rakesh K.; Batchelor, Tracy T.; Grossman, Stuart
Journal:
Neuro-oncology
Issue:
Volume 17:Issue 10(2015:Oct.)
Page Start:
1386
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. ACTR-14. PHASE I STUDY OF AZD1775 WITH RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) AND EVALUATION OF INTRATUMORAL DRUG DISTRIBUTION (IDD) IN PATIENTS WITH RECURRENT GBM. (5th November 2018)

Authors:
Alexander, Brian; Supko, Jeffrey; Agar, Nathalie; Ahluwalia, Manmeet; Desai, Arati; Dietrich, Jorg; Kaley, Thomas; Peereboom, David; Takebe, Naoko; Desideri, Serena; Fisher, Joy; Sims, Megan; Ye, Xiaobu; Ligon, Keith; Nabors, L Burt; Grossman, Stuart; Wen, Patrick
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 6
Page Start:
vi13
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. ACTR-43. GENOMIC ANALYSIS OF RESPONDERS OF PHASE II TRIAL OF TEMOZOLOMIDE AND TRC-102 (BASE EXCISION REPAIR INHIBITOR) IN BEVACIZUMAB-NAÏVE GLIOBLASTOMA AT FIRST RECURRENCE. (11th November 2019)

Authors:
Ahluwalia, Manmeet; Dhruv, Harshil; Fallah, Jaleh; Berens, Michael; Drappatz, Jan; Ye, Xiaobu; Lesser, Glenn; Cloughesy, Timothy; Walbert, Tobias; Holdhoff, Matthias; Peereboom, David; Nabors, Louis; Wen, Patrick; Grossman, Stuart; Rogers, Lisa
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 6
Page Start:
vi23
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. ACTR-58. BASELINE REQUIREMENTS FOR NOVEL AGENTS BEING CONSIDERED FOR BRAIN CANCER EFFICACY TRIALS: REPORT OF AN ABTC WORKSHOP. (11th November 2019)

Authors:
Grossman, Stuart; Romo, Carlos; Rudek-Renaut, Michelle; Supko, Jeffrey; Fisher, Joy; Nabors, Burt; Wen, Patrick; Peereboom, David; Ellingson, Benjamin; Ye, Xiaobu
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 6
Page Start:
vi27
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗